The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus

BackgroundDiabetes mellitus (DM) is a frequent comorbidity in patients with cancer. This study aimed to evaluate the prognosis of advanced non-small cell lung cancer (NSCLC) patients with DM and to assess whether an optimal glycemic control improves overall survival (OS).MethodsA total of 1279 advan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jie Qian, Weimin Wang, Lin Wang, Jun Lu, Lele Zhang, Bo Zhang, Shuyuan Wang, Wei Nie, Yanwei Zhang, Yuqing Lou, Baohui Han
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/4c22816da90c432d8dda3a08d0021e35
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!